Rational Design of a Combination Medication for the Treatment of Obesity-Reference-Cited by-同舟云学术

Rational Design of a Combination Medication for the Treatment of Obesity

Published:2009-01 Issue:1 Volume:17 Page:30-39
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:

Author:

Greenway Frank L.,Whitehouse M.J.,Guttadauria Maria,Anderson James W.,Atkinson Richard L.,Fujioka Ken,Gadde Kishore M.,Gupta Alok K.,O'Neil Patrick,Schumacher Donald,Smith Diane,Dunayevich Eduardo,Tollefson Gary D.,Weber Eckard,Cowley Michael A.

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/oby.2008.461/fullpdf

Reference45 articles.

1. Prevalence of overweight and obesity in the United States, 1999-2004;Ogden;JAMA,2006

2. Cause-specific excess deaths associated with underweight, overweight, and obesity;Flegal;JAMA,2007

3. Midlife body mass index and hospitalization and mortality in older age;Yan;JAMA,2006

4. Actual causes of death in the United States, 2000;Mokdad;JAMA,2004

5. The epidemic of obesity;Stein;J Clin Endocrinol Metab,2004

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of bupropion alone and combined with naltrexone on weight loss: a systematic review and meta-regression analysis of randomized controlled trials;Diabetology & Metabolic Syndrome;2024-04-24

2. Pharmacological treatments for adults with overweight and obesity without diabetes;Cochrane Database of Systematic Reviews;2024-04-18

3. Anti‐obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta‐analysis to inform the 2023 international evidence‐based guideline;Obesity Reviews;2024-02-14

4. Hypothalamic control of body fat mass by food intake: The key to understanding why obesity should be treated as a disease;Diabetes, Obesity and Metabolism;2024-02-14

5. Linea guida per la terapia del sovrappeso e dell’obesità resistenti al trattamento comportamentale nella popolazione adulta con comorbilità metaboliche;L'Endocrinologo;2024-01-31